FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912091368> ?p ?o ?g. }

• W2912091368 endingPage "289.e9" @default.
• W2912091368 startingPage "289.e1" @default.
• W2912091368 abstract "Our study aimed to analyze the potential association between clinical parameters and ERG expression and the outcome of docetaxel chemotherapy among patients with metastatic hormone-sensitive prostate cancer.Fifty-five patients with metastatic hormone-sensitive prostate cancer were treated with docetaxel in addition to androgen deprivation therapy. Patient characteristics, clinical factors, and tumor expression of ERG by immunohistochemistry were analyzed with respect to therapeutic response and survival data.Relapse free survival (RFS) and overal survival (OS) were 10.5 and 40.4 months, respectively, and both correlated with PSA response (RFS: 16.8 with a ≥50% decrease in PSA vs. 5.9 months in the case of <50% decrease, P < 0.001; OS: 40.4 vs. 11.6 months, respectively, P < 0.001). There was an association between OS and early progression (OS: 40.4 months with progression after 12 months vs. 17.9 months with progression within 12 months, P = 0.009). ERG expression was detected in 21 (42%) samples. ERG positivity was associated with favorable RFS (ERG pos. vs. neg.: 26.0 vs. 11.4 months, P = 0.003).ERG expression may have a potential predictive value with respect to the effectiveness and outcome of docetaxel chemotherapy combined with androgen deprivation therapy." @default.
• W2912091368 created "2019-02-21" @default.
• W2912091368 creator A5000876847 @default.
• W2912091368 creator A5005527997 @default.
• W2912091368 creator A5007654866 @default.
• W2912091368 creator A5010650581 @default.
• W2912091368 creator A5018405275 @default.
• W2912091368 creator A5022407603 @default.
• W2912091368 creator A5041331627 @default.
• W2912091368 creator A5043019374 @default.
• W2912091368 creator A5043979412 @default.
• W2912091368 creator A5049585950 @default.
• W2912091368 creator A5051508644 @default.
• W2912091368 creator A5068221701 @default.
• W2912091368 creator A5068554206 @default.
• W2912091368 creator A5075727033 @default.
• W2912091368 creator A5018499482 @default.
• W2912091368 date "2019-04-01" @default.
• W2912091368 modified "2023-10-09" @default.
• W2912091368 title "ERG expression can predict the outcome of docetaxel combinedwith androgen deprivation therapy in metastatic hormone-sensitiveprostate cancer" @default.
• W2912091368 cites W1489890125 @default.
• W2912091368 cites W1767148256 @default.
• W2912091368 cites W2000060994 @default.
• W2912091368 cites W2016571009 @default.
• W2912091368 cites W2026102934 @default.
• W2912091368 cites W2058484579 @default.
• W2912091368 cites W2104853034 @default.
• W2912091368 cites W2121158863 @default.
• W2912091368 cites W2150865892 @default.
• W2912091368 cites W2214621962 @default.
• W2912091368 cites W2289244923 @default.
• W2912091368 cites W2296157924 @default.
• W2912091368 cites W2301685087 @default.
• W2912091368 cites W2511949746 @default.
• W2912091368 cites W2549862740 @default.
• W2912091368 cites W2620746860 @default.
• W2912091368 cites W2620798309 @default.
• W2912091368 cites W2805640141 @default.
• W2912091368 cites W2810629266 @default.
• W2912091368 doi "https://doi.org/10.1016/j.urolonc.2018.12.007" @default.
• W2912091368 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30679082" @default.
• W2912091368 hasPublicationYear "2019" @default.
• W2912091368 type Work @default.
• W2912091368 sameAs 2912091368 @default.
• W2912091368 citedByCount "5" @default.
• W2912091368 countsByYear W29120913682020 @default.
• W2912091368 countsByYear W29120913682021 @default.
• W2912091368 countsByYear W29120913682022 @default.
• W2912091368 countsByYear W29120913682023 @default.
• W2912091368 crossrefType "journal-article" @default.
• W2912091368 hasAuthorship W2912091368A5000876847 @default.
• W2912091368 hasAuthorship W2912091368A5005527997 @default.
• W2912091368 hasAuthorship W2912091368A5007654866 @default.
• W2912091368 hasAuthorship W2912091368A5010650581 @default.
• W2912091368 hasAuthorship W2912091368A5018405275 @default.
• W2912091368 hasAuthorship W2912091368A5018499482 @default.
• W2912091368 hasAuthorship W2912091368A5022407603 @default.
• W2912091368 hasAuthorship W2912091368A5041331627 @default.
• W2912091368 hasAuthorship W2912091368A5043019374 @default.
• W2912091368 hasAuthorship W2912091368A5043979412 @default.
• W2912091368 hasAuthorship W2912091368A5049585950 @default.
• W2912091368 hasAuthorship W2912091368A5051508644 @default.
• W2912091368 hasAuthorship W2912091368A5068221701 @default.
• W2912091368 hasAuthorship W2912091368A5068554206 @default.
• W2912091368 hasAuthorship W2912091368A5075727033 @default.
• W2912091368 hasConcept C103796816 @default.
• W2912091368 hasConcept C118487528 @default.
• W2912091368 hasConcept C121608353 @default.
• W2912091368 hasConcept C126322002 @default.
• W2912091368 hasConcept C143998085 @default.
• W2912091368 hasConcept C204232928 @default.
• W2912091368 hasConcept C2776694085 @default.
• W2912091368 hasConcept C2777899217 @default.
• W2912091368 hasConcept C2777911890 @default.
• W2912091368 hasConcept C2780192828 @default.
• W2912091368 hasConcept C2780275930 @default.
• W2912091368 hasConcept C2780827179 @default.
• W2912091368 hasConcept C2781190966 @default.
• W2912091368 hasConcept C530470458 @default.
• W2912091368 hasConcept C71315377 @default.
• W2912091368 hasConcept C71924100 @default.
• W2912091368 hasConceptScore W2912091368C103796816 @default.
• W2912091368 hasConceptScore W2912091368C118487528 @default.
• W2912091368 hasConceptScore W2912091368C121608353 @default.
• W2912091368 hasConceptScore W2912091368C126322002 @default.
• W2912091368 hasConceptScore W2912091368C143998085 @default.
• W2912091368 hasConceptScore W2912091368C204232928 @default.
• W2912091368 hasConceptScore W2912091368C2776694085 @default.
• W2912091368 hasConceptScore W2912091368C2777899217 @default.
• W2912091368 hasConceptScore W2912091368C2777911890 @default.
• W2912091368 hasConceptScore W2912091368C2780192828 @default.
• W2912091368 hasConceptScore W2912091368C2780275930 @default.
• W2912091368 hasConceptScore W2912091368C2780827179 @default.
• W2912091368 hasConceptScore W2912091368C2781190966 @default.
• W2912091368 hasConceptScore W2912091368C530470458 @default.
• W2912091368 hasConceptScore W2912091368C71315377 @default.
• W2912091368 hasConceptScore W2912091368C71924100 @default.
• W2912091368 hasFunder F4320335322 @default.

• next